The Swern oxidation converts primary and secondary alcohols to aldehydes and ketones using DMSO activated by oxalyl chloride, without any chromium or manganese reagent. It is the standard metal-free oxidation in pharmaceutical synthesis wherever sensitive functional groups must be preserved.
RCH2OH + (CH3)2SO + (COCl)2 + 2 Et3N−78 °C, CH2Cl2→RCHO + (CH3)2S + CO + CO2 + 2 Et3N·HCl
Reaction 1: Overall Swern oxidation — primary alcohol to aldehyde
Reaction Mechanism
DMSO reacts with oxalyl chloride at −78 °C to form a chlorodimethylsulfonium intermediate, releasing carbon monoxide and carbon dioxide. The alcohol substrate then displaces chloride to form an alkoxysulfonium ion, and triethylamine deprotonates the methyl group adjacent to sulfur to generate an ylide that undergoes intramolecular elimination, yielding the carbonyl product and dimethyl sulfide.
The low temperature is critical: above −30 °C the activated sulfonium decomposes through Pummerer-type rearrangement, reducing yield and generating chlorinated byproducts. On scale, the exothermic activation step requires careful addition of oxalyl chloride to pre-cooled DMSO, and the order—oxalyl chloride, then alcohol, then triethylamine—must be followed so the activated sulfonium is fully formed before the substrate is introduced.
Where Swern Oxidation in DMSO Is Used
The reaction appears throughout macrolide antibiotic synthesis, where secondary alcohols on the macrocyclic ring are oxidized without disturbing acid-sensitive glycosidic bonds. It is also used in paclitaxel side-chain construction and prostaglandin syntheses, where stereoretentive oxidation sets ketone and aldehyde intermediates for subsequent coupling steps.
Primary alcohols stop cleanly at aldehydes with no over-oxidation to carboxylic acids, which is a key advantage over chromium-based reagents. The route is therefore preferred for late-stage API steps where over-oxidation or metal residue would otherwise complicate purification.
Functional-Group and Stereochemical Scope
Isolated alkenes, esters, amides, carbamates, acetals, and Boc or silyl protecting groups all survive the neutral-to-basic medium, and adjacent stereocenters are retained when base contact time is kept short. This broad tolerance makes the method suitable for chiral drug building blocks that cannot tolerate acidic or heavy-metal conditions.
| Product class | Industry | DMSO Swern step |
|---|---|---|
| Macrolide antibiotics | Pharma | Macrocyclic secondary alcohol → ketone |
| Paclitaxel / prostaglandin intermediates | Oncology / API | Stereoretentive alcohol → carbonyl |
| Chiral drug building blocks | Pharma R&D | Aldehyde without epimerization |
Table 1: Representative Swern oxidation applications using DMSO
Why DMSO Rather Than Heavy-Metal Oxidants
DMSO contributes the oxygen atom that becomes the carbonyl, so low-water, pharmaceutical-grade material is required: water above roughly 0.1% hydrolyzes the activated sulfonium and lowers yield. This reagent-grade DMSO specification is the main quality criterion for the reaction, rather than a long list of condition parameters.
Against PCC and Jones chemistry, the Swern route leaves no chromium or manganese residue in the product, which matters for API chains where residual metals are tightly controlled. Against the Kornblum route, Swern works directly from alcohols rather than halides and tolerates the broad functional-group list above; DMSO remains the oxidizing source in both systems.
References
- Mancuso, A.J.; Huang, S.L.; Swern, D. J. Org. Chem., 1978, 43(12), 2480–2482.
- Tidwell, T.T. Synthesis, 1990, 857–870.